M. Kraus & Co’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12M Sell
48,971
-486
-1% -$113K 3.49% 9
2025
Q4
$10.2M Sell
49,457
-301
-0.6% -$59.5K 2.86% 11
2025
Q3
$9.23M Sell
49,758
-879
-2% -$151K 2.58% 14
2025
Q2
$7.73M Sell
50,637
-734
-1% -$113K 2.27% 19
2025
Q1
$8.52M Sell
51,371
-305
-0.6% -$47.7K 2.59% 17
2024
Q4
$7.47M Sell
51,676
-636
-1% -$98.6K 2.24% 19
2024
Q3
$8.48M Sell
52,312
-1,064
-2% -$170K 2.48% 18
2024
Q2
$7.8M Sell
53,376
-538
-1% -$80K 2.39% 19
2024
Q1
$8.53M Buy
53,914
+253
+0.5% +$40.3K 2.59% 18
2023
Q4
$8.41M Sell
53,661
-476
-0.9% -$73K 2.74% 17
2023
Q3
$8.43M Sell
54,137
-4,350
-7% -$718K 2.99% 15
2023
Q2
$9.68M Buy
58,487
+305
+0.5% +$49.2K 3.25% 13
2023
Q1
$9.02M Buy
58,182
+1,426
+3% +$230K 3.18% 13
2022
Q4
$10M Buy
56,756
+2,142
+4% +$370K 3.7% 8
2022
Q3
$8.92M Buy
54,614
+395
+0.7% +$66.8K 3.74% 9
2022
Q2
$9.62M Buy
54,219
+68
+0.1% +$12.1K 3.72% 8
2022
Q1
$9.6M Buy
54,151
+325
+0.6% +$55.3K 3.23% 10
2021
Q4
$9.21M Buy
53,826
+593
+1% +$97.1K 2.93% 16
2021
Q3
$8.6M Buy
53,233
+708
+1% +$121K 3.06% 13
2021
Q2
$8.65M Buy
52,525
+1,079
+2% +$179K 3.11% 13
2021
Q1
$8.46M Buy
51,446
+550
+1% +$89K 3.28% 13
2020
Q4
$8.01M Buy
50,896
+1,960
+4% +$289K 3.34% 13
2020
Q3
$7.29M Buy
48,936
+952
+2% +$141K 3.44% 13
2020
Q2
$6.75M Buy
47,984
+823
+2% +$120K 3.49% 14
2020
Q1
$6.18M Sell
47,161
-280
-0.6% -$39.7K 3.75% 9
2019
Q4
$6.92M Buy
47,441
+260
+0.6% +$35.3K 3.45% 13
2019
Q3
$6.1M Buy
47,181
+1,986
+4% +$262K 3.31% 16
2019
Q2
$6.29M Buy
45,195
+736
+2% +$102K 3.5% 13
2019
Q1
$6.21M Buy
44,459
+105
+0.2% +$14.1K 3.63% 13
2018
Q4
$5.72M Sell
44,354
-48
-0.1% -$6.7K 3.78% 11
2018
Q3
$6.13M Buy
44,402
+405
+0.9% +$53.8K 3.55% 10
2018
Q2
$5.34M Buy
43,997
+5
+0% +$624 3.35% 12
2018
Q1
$5.64M Buy
43,992
+565
+1% +$76.4K 3.58% 12
2017
Q4
$6.07M Sell
43,427
-445
-1% -$62K 3.68% 10
2017
Q3
$5.7M Buy
43,872
+102
+0.2% +$13.5K 3.57% 9
2017
Q2
$5.79M Buy
43,770
+280
+0.6% +$35.7K 3.66% 9
2017
Q1
$5.42M Sell
43,490
-500
-1% -$59.7K 3.56% 9
2016
Q4
$5.07M Buy
43,990
+1,630
+4% +$188K 3.46% 11
2016
Q3
$5M Sell
42,360
-2,170
-5% -$263K 3.46% 10
2016
Q2
$5.4M Sell
44,530
-235
-0.5% -$26.7K 3.86% 5
2016
Q1
$4.84M Sell
44,765
-210
-0.5% -$21.7K 3.6% 6
2015
Q4
$4.62M Buy
44,975
+2,911
+7% +$293K 3.47% 8
2015
Q3
$3.93M Sell
42,064
-290
-0.7% -$28.1K 3.17% 11
2015
Q2
$4.13M Buy
42,354
+1,399
+3% +$140K 3% 15
2015
Q1
$4.12M Sell
40,955
-20
-0% -$2.03K 2.96% 13
2014
Q4
$4.29M Sell
40,975
-170
-0.4% -$17.9K 3.11% 13
2014
Q3
$4.39M Buy
41,145
+930
+2% +$96.5K 3.36% 8
2014
Q2
$4.21M Buy
40,215
+700
+2% +$70.8K 3.2% 10
2014
Q1
$3.88M Sell
39,515
-45
-0.1% -$4.17K 3.15% 11
2013
Q4
$3.62M Buy
+39,560
New +$3.65M 2.95% 13

Other funds holding JNJ

M. Kraus & Co's JNJ Position: Q1 2026 in Review

M. Kraus & Co reduced its Johnson & Johnson (JNJ) stake by 0.98% in Q1 2026, selling an estimated $113K and leaving 48,971 shares worth $12M. The position accounts for 3.49% of the portfolio, ranked #9.

M. Kraus & Co first reported a position in JNJ in Q4 2013 and has held it in 50 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • M. Kraus & Co held 48,971 shares of Johnson & Johnson worth $12M as of Q1 2026.
  • M. Kraus & Co sold 486 Johnson & Johnson shares in Q1 2026, an estimated $113K.
  • Johnson & Johnson made up 3.49% of M. Kraus & Co's portfolio in Q1 2026, its #9 holding.
  • M. Kraus & Co first reported a position in Johnson & Johnson in Q4 2013 and has held it in 50 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on M. Kraus & Co's 13F filing for Q1 2026, filed 14 Apr 2026.